Fera Pharmaceuticals Is A Specialty Pharmaceutical Company Founded In 2009 And Based In Locust Valleynew Yorkwith Around 20 Employees And $11 9 Million In Revenuefera Is Dedicated To Preserving And Expanding Treatment Options For Niche And Orphan Medical Conditionsparticularly In Ophthalmologythe Company Focuses On Developing And Commercializing Fda Approved Therapies While Maintaining A Pipeline Of Novel Candidates Fera S Commercialized Products Include Avaclyran Ophthalmic Ointment For Herpetic Keratitisand Keflexa First Generation Cephalosporin Antibioticthe Company Is Also Advancing Several Pipeline Productsincluding An Antiviral Ophthalmic Drug And A Corticosteroid Ophthalmic Formulationboth Pending Launchfera Prioritizes Ophthalmology And Is Exploring Expansion Into Other Therapeutic Areas As Opportunities Arisethe Company Targets Patients With Orphan Diseases And Healthcare Providers Specializing In Niche Ophthalmic Conditionsemphasizing A Patient Centric Approach To Address Gaps In Rare Disease Therapeutics
